The Weekly Roundup: What's Next in Supply Chain Safety? (6.14.19)
A pilot program announced this week seeks ways to use block chain technology to improve the prescription drug supply chain. “A permissioned block chain will provide an increased level of authority for patients and consumers, guaranteeing the drugs and vaccines they are receiving are not counterfeit, stolen, contaminated or harmful,” according to Craig Kennedy, senior vice president of supply chain at Merck, who is participating in the program with Walmart and technology partners IBM and KPMG. The new program is geared toward reducing the time associate with track-and-trace—a priority for the FDA based on its February program launch—and improving access and reliability. The potential for using the technology is vast, considering studies that have demonstrated that so much product is stolen, counterfeit, or damaged in transit. And while the so-called “porous” supply chain poses significant hazards to patients, it also adds significant cost to a system that has operated for decades in a black box.
Here are a few other stories that might be of interest:
- On the front line: Training urged to help pharmacists and emergency providers spot human trafficking.
- Here’s an interview that illuminates the policies on which the chains are focused.
- But is there any ROI? Making the case for MTM.
- On leveraging ALL the good ideas: There is no doubt adjusting to change is a necessity in today’s business climate, but are you getting in your own way?
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So, we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at email@example.com.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
On May 17, CMS announced its final rule on Medicare Part D and Medicare Advantage plans with a range of measures seeking greater transparency and negotiating power. The proposed rule had excited extensive comment from healthcare providers and patient advocacy groups on one aspect of the...
Repercussions from the U.S. measles outbreak continue to emerge. The latest victim: air travel, as officials leverage the CDC’s Do Not Board list as a deterrent against the spread of disease. As the summer travel season heats up, there is a range of co...